Long-acting therapies reshape hemophilia care beyond bleeding prevention < Hospital < Article
Treatment for hemophilia A is no longer limited to responding to bleeding episodes as they occur. To...
bleeding
Bleeding Disorders Treatment Global Market Review 2021-2025
Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Bleeding Disorders Treatment Market - Global Industry Size, Share, Trends, Opportunity, and...
New Model Predicts Bleeding Risks in Pediatric Liver Biopsies
In a groundbreaking study published in the esteemed journal BMC Pediatrics, a team of researchers led by Huang, Y., Zhou,...
Trust patient is first participant in Europe to join study of new treatment for rare bleeding disorder
Trust patient is first participant in Europe to join study of new treatment for rare bleeding disorder ...
Bleeding rates with severe hemophilia A fall with prophylaxis: Study
Prophylactic, or preventive, treatment with factor VIII (FVIII) replacement therapy for four years reduced annual bleeding rates by 91% for...
Revolutionary bio-sponge halts bleeding instantly
More than 11 million people in the United States take anticoagulation or antiplatelet medications, such as heparin or aspirin, to...
